Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rimegepant for Migraine Prevention in Japanese Subjects
Category & Conditions: Neurological Diseases and Conditions
Medicine: Nurtec® ODT (Rimegepant)
ClinicalTrials.gov Identifier (NCT): NCT05399485
Protocol ID: C4951021 (BHV3000-309)
Open Plain Language Summary Result:
Click here